MONTRÉAL, Dec. 18, 2020 (GLOBE NEWSWIRE) — Premier Health of America Inc. (formerly known as Physinorth Acquisition Corporation Inc.) (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its consolidated financial statements and MD&A for its fiscal year ended September 30, 2020.
Summary
“2020 was a period of many important milestones that we achieved while navigating through unprecedented times and I say with confidence that we surpassed our initial objectives.” Said Martin Legault, CEO of Premier Health. “These strong results and our recent major acquisition put us on an exceptional growth trajectory for 2021.”
FYE2020 Results Highlights
September 30, 2020 (12 months) |
September 30, 2019 (12 months) |
||||||
Revenues | $ | 20,739,973 | $ | 11,617,783 | |||
From last period | +78.5 | % | |||||
Gross margin | $ | 5,712,190 | $ | 2,554,955 | |||
From last period | +123.6 | % | |||||
EBITDA (1) | $ | 2,120,630 | $ | 868,408 | |||
From last period | +144.2 | % |
(1) Adjusted EBITDA before non-recurring items
Business Highlights
Financing Highlights
Completion of Acquisition of Code Bleu
Premier Health completed the previously announced Code Bleu acquisition on November 6 for a total consideration of C$17 million. The acquisition was financed by a $10M five year term loan bearing interest at prime rate plus 1.55%, the issuance of 6,521,740 common shares of the Corporation at $0.69 per share and a $2.5M balance of sale subject to performance objectives. Code Bleu is a prominent Quebec agency employing nurses, caregivers, dental staff and other health-related personnel. Code Bleu’s mission is to offer its various public and private partners with quality, efficient and safe services provided by its highly qualified staff. For the year ending December 31, 2019, Code Bleu generated revenues of approximately C$29.3M, an EBITDA of C$3.9M and a net income of C$2.8M.
About Premier Health
Premier Health is a leading Canadian Healthtech company that provides a comprehensive range of staffing and outsourced services solutions for healthcare needs to governments, corporations, and individuals. Premier Health uses its proprietary PSweb platform to lead the healthcare services sector digital transformation to provide patients with faster, cheaper and more accessible care services.
Non-GAAP Measures
Earnings before interest, taxes, depreciation and amortization (“EBITDA”), is calculated as the net profit (loss), before non-recurring items such as acquisition and transaction costs, non-cash expenses (including loss from disposal of assets, impairments, amortization and depreciation), interest expense, net of interest income and income tax expense.
For Further Information Please Contact:
Mr. Jean-Robert Pronovost
Vice-President, Corporate Development
Premier Health of America Inc.
(formerly known as Physinorth Acquisition Corporation Inc.)
jrpronovost@premierhealth.ca / 514-581-1473
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This press release contains forward-looking information based on current expectations. Statements about the date of trading of the Corporation’s common shares on the Exchange and final regulatory approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Corporation assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. These factors and others are more fully discussed in the filings of the Corporation with Canadian securities regulatory authorities available at www.sedar.com.
Amazfit Active becomes the world's first smartwatch under €200 to fully-integrate AI. MILPITAS, Calif., July…
Investment will support investigation of Mission's small molecule drug MTX325 in patients with early-stage Parkinson's…
New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/…
Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the…
Change of Registered AddressLONDON, UK / ACCESSWIRE / July 2, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg'…
GOTHENBURG, SWEDEN / ACCESSWIRE / July 2, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…